Cosmo Pharmaceuticals S.p.A. operates as a specialty pharmaceutical company primarily in Italy. The company develops, licenses, and commercializes proprietary pharmaceutical products, primarily for the treatment of inflammatory bowel diseases, colon infections, and other colon diseases, as well as topically treated skin disorders; and manufactures pharmaceutical products for third parties and provides related services. Its products comprise Lialda, Mezavant, and Mesavancol proprietary formulations for mild to moderate ulcerative colitis; Uceris and Cortiment products for mild to moderate ulcerative colitis; and Zacol NMX, a nutraceutical product for intestinal disorders. The company also develops various products, including CB-17-01 Methylene Blue MMX, a vital dye which stains the living cells that is in Phase III clinical trials for colon cancer; SIC 8000, a submucosal injectable composition developed to reduce the risk of perforation when resecting flat polyps and to allow the resection of large polyps in one piece; Rifamycin SV MMX, a semisynthetic, orally poorly absorbable antibiotic for the treatment of bacterial infections of the colon, which has completed phase III clinical trials in traveler’s diarrhea; CB-03-01, a steroidal anti-androgen drug, cortexolone 17a-proprionate (CB-03-01) 1% cream, targeted at acne, alopecia, hirsutism and possibly seborrhea that has Phase II clinical trials for acne; CB-06-02, a tellurium-based compound for the topical treatment of HPV and genital warts that is in Phase II trial; and CB-06-01, a topical antibiotic for the treatment of acne, which in Phase II trial. The company is headquartered in Luxembourg.
cosmo pharmaceuticals spa
(COPN:SIX Swiss Ex)
37C, avenue John F. Kennedy
Phone: 352 2784 8749
|Alkermes PLC||$64.12 USD||+0.28|
|Depomed Inc||$28.62 USD||+7.98|
|Durect Corp||$2.37 USD||-0.03|
|Supernus Pharmaceuticals Inc||$17.66 USD||+0.36|
|Veloxis Pharmaceuticals A/S||kr0.84 DKK||-0.01|
|View Industry Companies|
Sponsored Financial Commentaries
To contact COSMO PHARMACEUTICALS SPA, please visit www.cosmopharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.